Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Continuum Investment Partners is a private investment firm and angel group that specializes in early-stage investments within the life sciences, biotechnology, and healthcare technology sectors. The firm typically provides seed and early-stage capital to companies developing proprietary products or services that enhance operating efficiencies in targeted medical markets. Continuum is known for taking an active management role in its portfolio companies, often securing board representation to guide strategic growth and commercialization. Its portfolio has historically included notable biotech entities such as Cellectar Biosciences, where the firm's leadership has played a significant role in governance and financing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Continuum Investment.